Layoffs
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past.
The first of the pink slips at Sandoz’ generic-drug manufacturing facility in Broomfield, Colo. have been handed out.
Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn.
The cuts were apparently announced in late January with a WARN notice filed with the state.
Koss said affected employees will receive severance benefits and career guidance.
A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.
Vical announced its restructuring late Tuesday.
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
Novelion will slash an unknown number of jobs as it initiates “significant cost reduction plans.”
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
PRESS RELEASES
